Complete Filing Data
Spark I Acquisition Corp reported Stockholders Equity of -$7.15 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Spark I Acquisition Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Income * | $293.6K | $3.2M | -$730.9K | -$1.3M |
| Nonoperating Income Expense | $2.9M | $5.2M | $1.2M | $4.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$475.2K | $362.6K | $542.3K | $902.0K | $870.8K | $770.4K | -$448.1K | -$443.1K | -$353.4K | -$277.2K | -$343.4K | -$271.6K |
| Nonoperating Income Expense | $392.6K | $1.1M | $1.1M | $1.4M | $1.3M | $1.3M | $1.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Stockholders Equity | -$7.2M | -$4.4M | -$2.3M | -$1.8M | -$429.4K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $112.3K | $375.4K | $1.4M | $587.6K | $251.2K |
| Retained Earnings Accumulated Deficit | -$7.2M | -$4.4M | -$2.5M | -$1.8M | |
| Liabilities Current | $3.8M | $1.3M | $408.7K | $3.1M | |
| Liabilities And Stockholders Equity | $25.4M | $107.4M | $103.3M | $1.3M | |
| Assets Current | $193.4K | $479.8K | $1.6M | $675.1K | |
| Assets | $25.4M | $107.4M | $103.3M | $1.3M | |
| Accrued Liabilities Current | $604.1K | $505.2K | $408.7K | $316.7K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$263.1K | -$1.0M | $816.5K | ||
| Cash And Cash Equivalents At Carrying Value | $112.3K | $375.4K | $1.4M | ||
| Liabilities | $7.3M | $4.8M | $3.9M | $3.1M | |
| Assets Held In Trust Noncurrent | $25.2M | $106.9M | $101.7M | ||
| Deferred Compensation Liability Classified Noncurrent | $3.5M | $3.5M | $3.5M | ||
| Unrealized Gain Loss On Investments | $2.9M | $5.2M | |||
| Temporary Equity Accretion To Redemption Value | $3.1M | $5.2M | $12.3M | ||
| Other Liabilities Current | $3.5K | $3.5K | |||
| Temporary Equity Accretion To Redemption Value Adjustment | -$12.3M | ||||
| Other Assets Noncurrent | $77.2K | ||||
| Convertible Notes Payable Current | $1.5M | ||||
| Accounts Payable Current | $3.5K | ||||
| Notes Payable Current | $2.8M | ||||
| Deferred Costs | $629.4K | ||||
| Accrued Offering Costs | |||||
| Notes Payable Excluding Convertible Note Current | $1.7M | ||||
| Debt Forgiveness Amount | $1.2K | ||||
| Repayments Of Notes Payable | $3.8M | ||||
| Conversion Of Advances To Convertible Notes Payable | |||||
| Cash Equivalents At Carrying Value | $1.4M | $587.6K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | $816.5K | $336.5K | |||
| Deferred Offering Costs Included In Accrued Offering Costs | $238.9K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$6.7M | -$5.7M | -$4.9M | -$3.8M | -$3.3M | -$2.8M | -$3.0M | -$2.6M | -$2.1M | -$1.3M | -$1.0M | -$701.0K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $614.0K | $1.1M | $487.2K | $82.8K | $471.2K | $932.7K | $113.6K | $96.2K | $158.0K | $1.0M | ||||
| Retained Earnings Accumulated Deficit | -$6.7M | -$5.7M | -$4.9M | -$3.8M | -$3.3M | -$2.8M | -$3.0M | |||||||
| Liabilities Current | $3.8M | $3.4M | $2.1M | $458.9K | $449.9K | $507.7K | $4.2M | |||||||
| Liabilities And Stockholders Equity | $25.5M | $110.3M | $108.6M | $105.9M | $105.0M | $104.2M | $1.2M | |||||||
| Assets Current | $639.2K | $1.2M | $603.9K | $207.4K | $627.4K | $1.1M | $184.7K | |||||||
| Assets | $25.5M | $110.3M | $108.6M | $105.9M | $105.0M | $104.2M | $1.2M | |||||||
| Accrued Liabilities Current | $573.1K | $843.1K | $606.6K | $455.4K | $446.4K | $504.2K | $18.4K | |||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $111.8K | -$471.5K | -$429.6K | |||||||||||
| Cash And Cash Equivalents At Carrying Value | $614.0K | $1.1M | $487.2K | $82.8K | $471.2K | $932.7K | $113.6K | $587.6K | ||||||
| Liabilities | $7.3M | $6.9M | $5.6M | $4.0M | $3.9M | $4.0M | ||||||||
| Assets Held In Trust Noncurrent | $24.8M | $109.2M | $108.0M | $105.7M | $104.3M | $103.0M | $0.00 | |||||||
| Deferred Compensation Liability Classified Noncurrent | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | $3.5M | ||||||||
| Unrealized Gain Loss On Investments | $391.4K | $1.1M | $1.4M | $1.3M | ||||||||||
| Temporary Equity Accretion To Redemption Value | $1.1M | $1.3M | ||||||||||||
| Other Liabilities Current | $3.5K | $3.5K | $3.5K | |||||||||||
| Temporary Equity Accretion To Redemption Value Adjustment | $1.4M | $1.3M | $1.3M | |||||||||||
| Other Assets Noncurrent | $25.8K | $51.5K | ||||||||||||
| Convertible Notes Payable Current | $1.5M | $1.5M | $1.4M | $840.0K | ||||||||||
| Accounts Payable Current | $3.5K | $3.5K | $3.5K | $5.5K | ||||||||||
| Notes Payable Current | $3.8M | |||||||||||||
| Deferred Costs | $999.9K | |||||||||||||
| Accrued Offering Costs | $417.4K | $316.6K | ||||||||||||
| Notes Payable Excluding Convertible Note Current | $1.7M | $1.0M | ||||||||||||
| Debt Forgiveness Amount | $1.2K | |||||||||||||
| Repayments Of Notes Payable | ||||||||||||||
| Conversion Of Advances To Convertible Notes Payable | $840.0K | |||||||||||||
| Cash Equivalents At Carrying Value | ||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | ||||||||||||||
| Deferred Offering Costs Included In Accrued Offering Costs |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$2.5M | -$1.9M | -$1.3M | -$1.1M |
| Increase Decrease In Prepaid Expense | -$23.3K | -$52.1K | $69.0K | -$116.4K |
| Increase Decrease In Accrued Expenses And Offering Costs | $98.8K | $96.5K | $92.0K | |
| Net Cash Provided By Used In Financing Activities | -$82.4M | $840.0K | $102.6M | $1.5M |
| Increase Decrease In Other Operating Capital Net | -$77.2K | $77.2K | ||
| Increase Decrease In Due To Related Parties | $3.5K | |||
| Increase Decrease In Deferred Charges | -$629.4K | |||
| Proceeds From Issuance Of Debt | $1.0M | $1.8M | ||
| Payments Of Financing Costs | $3.1M | $272.7K | ||
| Net Cash Provided By Used In Investing Activities | $84.6M | -$100.5M | ||
| Increase Decrease In Other Accrued Liabilities | $92.0K | -$12.1K | ||
| Proceeds From Notes Payable | $840.0K | |||
| Proceeds From Issuance Of Private Placement | $8.5M | |||
| Proceeds From Issuance Of Common Stock | $100.0M | |||
| Proceeds From Cash Withdrawn From Trust Account | $84.8M | |||
| Payments To Acquire Investments | $100.5M | |||
| Payments For Repurchase Of Common Stock | $84.8M | |||
| Increase Decrease In Other Noncurrent Assets | $77.2K | -$87.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$488.2K | -$471.5K | -$326.9K |
| Increase Decrease In Prepaid Expense | $12.3K | $40.3K | -$32.2K |
| Increase Decrease In Accrued Expenses And Offering Costs | $101.4K | $95.5K | $13.9K |
| Net Cash Provided By Used In Financing Activities | $600.0K | -$102.7K | |
| Increase Decrease In Other Operating Capital Net | -$25.7K | $18.4K | |
| Increase Decrease In Due To Related Parties | $3.5K | ||
| Increase Decrease In Deferred Charges | $1.3K | ||
| Proceeds From Issuance Of Debt | |||
| Payments Of Financing Costs | $102.7K | ||
| Net Cash Provided By Used In Investing Activities | |||
| Increase Decrease In Other Accrued Liabilities | |||
| Proceeds From Notes Payable | $600.0K | ||
| Proceeds From Issuance Of Private Placement | |||
| Proceeds From Issuance Of Common Stock | |||
| Proceeds From Cash Withdrawn From Trust Account | |||
| Payments To Acquire Investments | |||
| Payments For Repurchase Of Common Stock | |||
| Increase Decrease In Other Noncurrent Assets |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | ||||
| Pro Forma Weighted Average Shares Outstanding Diluted | ||||
| Earnings Per Share Diluted | ||||
| Earnings Per Share Basic | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Weighted Average Number Of Shares Outstanding Basic | 6.4M | 6.4M | 6.4M | 6.4M | |||||
| Pro Forma Weighted Average Shares Outstanding Diluted | 6.4M | 6.4M | 6.4M | 6.4M | |||||
| Earnings Per Share Diluted | $-0.05 | $0.05 | $-0.07 | $-0.04 | |||||
| Earnings Per Share Basic | $-0.05 | $0.05 | $-0.07 | $-0.04 | |||||
| Common Stock Par Or Stated Value Per Share |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Operating Costs And Expenses | $1.6M | $848.6K | $657.5K | $74.5K |
| Costs And Expenses | $2.6M | $2.1M | $1.9M | $1.3M |
| Administrative Fees Expense | $1.0M | $1.2M | $1.3M | $1.3M |
| Prepaid Expense Current | $81.1K | $104.4K | $156.5K | $87.5K |
| Investment Income Interest | $2.9M | $5.2M | $1.2M | |
| Interest Income Operating | $4.00 | $4.00 | $1.00 | $4.00 |
| Remeasurement Of Ordinary Shares To Redemption Amount | 3.1M | 5.2M | 12.3M | |
| Additional Paid In Capital | $246.7K | $24.3K | ||
| Related Party Transaction Amounts Of Transaction | ||||
| Notes Advance Amount Current | $840.0K | |||
| Payment For Deposits Into Trust Account | $201.3K | |||
| Adjustments To Additional Paid In Capital Warrant Issued | $8.4M | |||
| Adjustments To Additional Paid In Capital Mark To Market | $4.2M | |||
| Conversion Of Stock Amount Converted1 | $400.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Costs And Expenses | $595.0K | $478.2K | $307.7K | $142.3K | $138.7K | $234.7K | $373.4K | $388.3K | $339.5K | $239.7K |
| Costs And Expenses | $867.8K | $763.9K | $577.4K | $454.6K | $470.2K | $555.9K | $448.1K | $443.1K | $353.4K | $277.2K |
| Administrative Fees Expense | $272.8K | $285.7K | $269.7K | $312.4K | $331.5K | $321.2K | $74.7K | $54.8K | $13.8K | |
| Prepaid Expense Current | $25.2K | $74.7K | $116.7K | $124.7K | $156.2K | $196.8K | $71.1K | |||
| Investment Income Interest | $1.1M | $1.00 | $2.00 | $1.3M | $1.00 | |||||
| Interest Income Operating | $1.00 | $1.00 | $1.00 | $1.00 | $2.00 | $1.00 | ||||
| Remeasurement Of Ordinary Shares To Redemption Amount | 492.0K | 1.1M | 1.1M | 1.4M | 1.3M | 1.3M | ||||
| Additional Paid In Capital | $24.3K | |||||||||
| Related Party Transaction Amounts Of Transaction | $74.7K | $37.5K | ||||||||
| Notes Advance Amount Current | ||||||||||
| Payment For Deposits Into Trust Account | ||||||||||
| Adjustments To Additional Paid In Capital Warrant Issued | ||||||||||
| Adjustments To Additional Paid In Capital Mark To Market | ||||||||||
| Conversion Of Stock Amount Converted1 |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.